SciClone Pharmaceuticals (SCLN) Gains; DC Bead Approved by China FDA
Tweet Send to a Friend
SciClone Pharmaceuticals, Inc. (NASDAQ: SCLN), and its partner BTG plc today announced that the China Food and Drug Administration has ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE